Biocompare Proudly Announces the Next Iteration of Future Lab: Trends in Next-Gen Sequencing (NGS)
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: PR Web
SOUTH SAN FRANCISCO, Calif. (PRWEB) August 30, 2021 Biocompare is proud to announce the next iteration of Future Lab: Trends in Next-Gen Sequencing (NGS), an in-depth multimedia content hub that focuses on this fast-paced field. This information resource has been designed to keep life science researchers up to date on the latest news, trends and breakthroughs in NGS.By collaborating with multiple sponsors such as 10X Genomics, Agilent, Beckman Coulter Life Sciences, Hamilton, Cellecta and Levitas Bio, Trends in Next-Gen Sequencing has compiled an extensive library of original articles and webinars covering every step of the NGS process and the applications that depend on it."The pace of development of Next-Gen Sequencing is just stunning," says Joan Boyce, VP and General Manager of Biocompare, "It is now an integral part of not just basic research but has also become an important tool in the clinic. It's an exciting time and we hope to keep researchers up to date on the latest breakt
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics to Present at the BofA Securities 2024 Healthcare ConferencePR Newswire
- 10x Genomics First Quarter 2024 Earnings: In Line With Expectations [Yahoo! Finance]Yahoo! Finance
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at UBS Group AG from $52.00 to $30.00. They now have a "neutral" rating on the stock.MarketBeat
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $30.00 to $26.00. They now have a "sell" rating on the stock.MarketBeat
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Bank of America Co. from $45.00 to $36.00. They now have a "neutral" rating on the stock.MarketBeat
TXG
Earnings
- 4/30/24 - Miss
TXG
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/26/24 - Form DEFA14A
- TXG's page on the SEC website